Amgen Inc. v. Sandoz Inc.
| AMGEN INC. |
| SANDOZ INC., MANKIND PHARMA LTD., TORRENT PHARMACEUTICALS LTD., GLENMARK PHARMACEUTICALS LIMITED, MACLEODS PHARMACEUTICALS LTD., MSN LABORATORIES PRIVATE LTD., ACTAVIS LLC, PRINSTON PHARMACEUTICAL INC., EMCURE PHARMACEUTICALS LTD., AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., ANNORA PHARMA PRIVATE LIMITED, HETERO USA, INC., CIPLA LIMITED, ALKEM LABORATORIES LTD., ZYDUS PHARMACEUTICALS (USA) INC., DR. REDDY'S LABORATORIES, INC., DR. REDDY'S LABORATORIES, LTD., AMNEAL PHARMACEUTICALS LLC and PHARMASCIENCE INC. |
| 22-1149 |
| November 12, 2021 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 30, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [ # 8 ], ERROR: Documents were filed in a member case.. CORRECTION: The parties must file all documents in the lead appeal only 22-1147. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [815359] [JCW] [Entered: 11/30/2021 02:18 PM] |
| Filing 8 Amended Entry of appearance for Michael J. Gaertner; Hugh S. Balsam; David B. Abramowitz; Carolyn A. Blessing; Emily L. Savas; August M. Melcher as counsel for Appellee Zydus Pharmaceuticals (USA) Inc.. Service: 11/30/2021 by email. [815358] [22-1149] [David Abramowitz] [Entered: 11/30/2021 02:13 PM] |
| Filing 7 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [ # 6 ], Doc No. [ # 5 ], ERROR: Documents were filed in a member case. CORRECTION: The parties must file all documents in the lead appeal only 22-1147. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [814204] [JCW] [Entered: 11/22/2021 03:46 PM] |
| Filing 6 Certificate of Interest for Appellee Zydus Pharmaceuticals (USA) Inc.. Service: 11/22/2021 by email. [814189] [22-1149] [David Abramowitz] [Entered: 11/22/2021 03:31 PM] |
| Filing 5 Entry of appearance for Michael J. Gaertner; Hugh S. Balsam; David B. Abramowitz; Carolyn A. Blessing as counsel for Appellee Zydus Pharmaceuticals (USA) Inc.. Service: 11/22/2021 by email. [814187] [22-1149] [David Abramowitz] [Entered: 11/22/2021 03:30 PM] |
Filing 4
Note to File: The following cases are consolidated: 22-1147 Lead with 22-1149 Cross-appeal, with 22-1150 Member Case with 22-1151 Cross-Appeal. The parties must file all documents in the lead appeal only. [813519] [22-1147, 22-1149, 22-1150, 22-1151] [JCW] [Entered: 11/18/2021 04:09 PM]
|
|
Filing 3
ORDER consolidating appeals (22-1147, 22-1149, 22-1150, 22-1151). Appellants opening briefs are due no later than January 14, 2022. Service as of this date by the Clerk of Court. [813518] [22-1147, 22-1150, 22-1149, 22-1151] [JCW] [Entered: 11/18/2021 04:06 PM]
|
|
Filing 2
Note to File: The following cases are consolidated: 22-1147 Lead with 22-1149 Cross-Appeal. The parties must file all documents in the lead appeal only. [811866] [22-1147, 22-1149] [JCW] [Entered: 11/12/2021 12:37 PM]
|
|
Filing 1
Appeal docketed. Received: 10/28/2021. [811855] Entry of Appearance is due on 11/29/2021. Certificate of Interest is due on 11/29/2021. Docketing Statement is due on 11/29/2021. Appellant's brief is due on 01/11/2022. [JCW] [Entered: 11/12/2021 12:14 PM]
|
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
